Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|June 26, 2019
Mutations in pmrB Confer Cross-Resistance between the LptD Inhibitor POL7080 and Colistin in Pseudomonas aeruginosaKeith P Romano, Thulasi Warrier, Bradley E Poulsen, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosisBen Gold, Julia Roberts, Yan Ling, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Perturbation-Specific Transcriptional Mapping for unbiased target elucidation of antibioticsKeith P Romano, Josephine Bagnall, Thulasi Warrier, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2024
Perturbation-specific transcriptional mapping for unbiased target elucidation of antibioticsKeith P Romano, Josephine Bagnall, Thulasi Warrier, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesisThulasi Warrier, Marielle Tropis, Jim Werngren, et al.
Science Translational Medicine|November 24, 2021
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetectedKohta Saito, Saurabh Mishra, Thulasi Warrier, et al.
Journal of Medicinal Chemistry|April 4, 2014
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosisPurong Zheng, Selin Somersan-Karakaya, Shichao Lu, et al.
European Journal of Medicinal Chemistry|February 22, 2014
Benzimidazole-based compounds kill Mycobacterium tuberculosisYaling Gong, Selin Somersan Karakaya, Xiaoyong Guo, et al.
Mbio|November 22, 2018
Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of TreatmentKathrine McAulay, Kohta Saito, Thulasi Warrier, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2017
Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populationsKohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, et al.
Pageof 4